Response to “Steroid-Limited Isatuximab-Based Quadruplet Therapy in Elderly, Transplant-Ineligible Multiple Myeloma: A REST Trial Commentary”
Authors:
- Frida Bugge AskelandFAFrida Bugge Askeland
- Fredrik SchjesvoldFSFredrik Schjesvold
Open Access
- 1 April 2026
- journal article
- Published by AME Publishing Company in AME Clinical Trials Review
- Vol. 4, 20